17th Mar 2014 07:00
RNS Number : 4052C
Allergy Therapeutics PLC
17 March 2014
17 March 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Notice of results
Allergy Therapeutics plc (AIM: "AGY" or the "Company"), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, will announce its Interim Results for the six months ended 31 December 2013 on Monday 24 March 2014.
- Ends -
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite Finance Director |
|
|
|
FTI Consulting |
|
Simon Conway / Victoria Foster-Mitchell | +44 (0) 20 3727 1000 |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Allergy Thera.